11/13/2024
1:41 PM | Ironwood Pharmaceuticals (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SCHEDULE 13G | |
11/12/2024
2:47 PM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
4:22 PM | Ironwood Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
10:46 AM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/16/2024
9:04 AM | Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
|
09/30/2024
6:00 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:05 PM | DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
6:30 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
12:35 PM | Ironwood Pharmaceuticals (Subject)
Moukheibir Catherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
3:46 PM | Ironwood Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:09 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:26 PM | Ironwood Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024
3:28 PM | Ironwood Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024
3:31 PM | Ironwood Pharmaceuticals (Filer)
| Form ARS | |
02/16/2024
6:01 AM | Ironwood Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
6:04 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:01 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:50 PM | Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:53 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:35 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:39 PM | Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:42 PM | Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
2:12 PM | Ironwood Pharmaceuticals (Subject)
LSV ASSET MANAGEMENT (Filed by)
| Form SC 13G/A | |
01/25/2024
8:21 AM | Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
1:03 PM | BlackRock Inc. (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024
3:05 PM | Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:05 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:05 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:05 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
9:16 AM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/08/2024
5:05 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
3:26 PM | Ironwood Pharmaceuticals (Subject)
Kessler Marla L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
